Portfolio (Quarterly)
Guide ↗
Bellevue Group AG
· CIK 0001674546| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | SYK | STRYKER CORPORATION | Healthcare | 217,237.0 | $71.4M | 1.70% | -143K | -39.8% | $328.59 | -2.2% |
| 22 | PCVX | VAXCYTE INC | Healthcare | 1,190,697.0 | $69.2M | 1.65% | NEW | — | $58.11 | -18.4% |
| 23 | VERA | VERA THERAPEUTICS INC | Healthcare | 1,710,771.0 | $68.8M | 1.64% | +13K | +0.7% | $40.23 | -13.9% |
| 24 | EW | EDWARDS LIFESCIENCES CORP | Healthcare | 839,451.0 | $67.2M | 1.60% | -204K | -19.5% | $80.08 | +3.9% |
| 25 | — | DAMORA THERAPEUTICS INC | — | 2,298,000.0 | $59.5M | 1.42% | NEW | — | $25.90 | — |
| 26 | TNGX | TANGO THERAPEUTICS INC | Healthcare | 2,400,000.0 | $50.2M | 1.20% | -1.5M | -38.9% | $20.92 | +0.8% |
| 27 | IDXX | IDEXX LABS INC | Healthcare | 89,131.0 | $50.1M | 1.19% | -5K | -5.7% | $561.89 | -1.6% |
| 28 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 2,380,000.0 | $49.9M | 1.19% | +2.4M | +10000.0% | $20.95 | +11.6% |
| 29 | DXCM | DEXCOM INC | Healthcare | 788,766.0 | $49.5M | 1.18% | -59K | -6.9% | $62.80 | +14.5% |
| 30 | JBIO | JADE BIOSCIENCES INC | Healthcare | 3,501,502.0 | $49.2M | 1.17% | +160K | +4.8% | $14.05 | +67.0% |
| 31 | EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | 1,528,518.0 | $48.1M | 1.15% | — | — | $31.50 | +3.8% |
| 32 | UNH | UNITEDHEALTH GROUP INC | Healthcare | 148,203.0 | $40.1M | 0.95% | -27K | -15.4% | $270.59 | +41.7% |
| 33 | DHR | DANAHER CORP DEL | Healthcare | 202,164.0 | $38.3M | 0.91% | +8K | +3.9% | $189.60 | -8.6% |
| 34 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 1,200,000.0 | $38.1M | 0.91% | -2.4M | -66.8% | $31.72 | -3.6% |
| 35 | RMD | RESMED INC | Healthcare | 159,346.0 | $35.8M | 0.85% | -2K | -1.2% | $224.48 | -6.5% |
| 36 | PODD | INSULET CORP | Healthcare | 163,656.0 | $34.3M | 0.82% | -23K | -12.3% | $209.84 | -25.4% |
| 37 | TMO | THERMO FISHER SCIENTIFIC INC | Healthcare | 64,412.0 | $31.7M | 0.75% | -665.0 | -1.0% | $491.53 | -8.1% |
| 38 | LLY | ELI LILLY & CO | Healthcare | 33,932.0 | $31.2M | 0.74% | — | — | $919.77 | +13.3% |
| 39 | GEHC | GE HEALTHCARE TECHNOLOGIES I | Healthcare | 416,887.0 | $29.7M | 0.71% | -8K | -1.8% | $71.18 | -9.6% |
| 40 | — | DISC MEDICINE INC | — | 459,314.0 | $29.4M | 0.70% | NEW | — | $63.94 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Technology
0.2%
Energy
0.1%
Financial Services
0.1%
Consumer Cyclical
0.0%
Communication Services
0.0%
Consumer Defensive
0.0%